Aligning pharmaceutical innovation with medical need

被引：35
作者：
Nathan, Carl [1 ]
机构：
[1] Cornell Univ, Weill Med Coll, New York, NY 10021 USA
来源：
NATURE MEDICINE | 2007年 / 13卷 / 03期
关键词：
D O I：
10.1038/nm0307-304
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
引用
收藏
页码：304 / 308
页数：5
相关论文
共 32 条
[1]  
Abramowicz M, 2003, VANDERBILT LAW REV, V56, P115
[2]   The patents-based pharmaceutical development process: Rationale, problems, and potential reforms [J].
Barton, JH ;
Emanuel, EJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2005, 294 (16) :2075-2082
[3]   Universities urged to do more for poor nations [J].
Check, Erika .
NATURE, 2006, 444 (7118) :412-413
[4]   Global framework on essential health R&D [J].
Chirac, P ;
Torreele, E .
LANCET, 2006, 367 (9522) :1560-1561
[5]   New antibiotics from bacterial natural products [J].
Clardy, Jon ;
Fischbach, Michael A. ;
Walsh, Christopher T. .
NATURE BIOTECHNOLOGY, 2006, 24 (12) :1541-1550
[6]   Drug discovery in jeopardy [J].
Cuatrecasas, Pedro .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (11) :2837-2842
[7]   Differential Pricing for Pharmaceuticals: Reconciling Access, R&D and Patents [J].
Patricia M. Danzon ;
Adrian Towse .
International Journal of Health Care Finance and Economics, 2003, 3 (3) :183-205
[8]  
DUGGER C, 2006, NY TIMES 1201, pA9
[9]   Developing a new resource for drug discovery: marine actinomycete bacteria [J].
Fenical, William ;
Jensen, Paul R. .
NATURE CHEMICAL BIOLOGY, 2006, 2 (12) :666-673
[10]   Paying for performance - Risks and recommendations [J].
Fisher, Elliott S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (18) :1845-1847
1234